Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04799535 · ClinicalTrials.gov registry record
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
A clinical trial of Breast Carcinoma and Breast Neoplasm, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT04799535: Recruiting study of Breast Carcinoma and Breast Neoplasm, sponsored by Mayo Clinic.
NCT04799535 is a study of Breast Carcinoma and Breast Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 550 participants, below the 765-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04799535, a study of Breast Carcinoma and Breast Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the breast, and assess response to breast cancer treatment.
Primary Outcome
Will be reported including 95% confidence intervals derived from the cross-validation procedure.
Conditions Studied
Interventions
- PROCEDURE Ultrasound
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2027-11-29 |
What NCT04799535 shows while recruiting
NCT04799535 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 765-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (28% lower).
The record links to 2 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT04799535 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04799535 about?
NCT04799535 is a clinical study titled "Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring". This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test...
What is the current status of trial NCT04799535?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2019-09-01. Estimated completion is 2027-11-29.
What conditions does trial NCT04799535 study?
This clinical trial studies the following conditions: Breast Carcinoma, Breast Neoplasm.
What interventions are being tested in trial NCT04799535?
The interventions under investigation include: Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT04799535?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04799535 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04799535's enrollment target sits among peer trials
550 20th of 106 higher than 87 of 106 other Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI